Found: 12
Select item for more details and to access through your institution.
Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials
- Published in:
- International Journal of Clinical Practice (Supplement), 2015, v. 69, n. 12, p. 1496, doi. 10.1111/ijcp.12722
- By:
- Publication type:
- Article
Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life.
- Published in:
- International Journal of Clinical Practice, 2005, v. 59, n. 5, p. 579, doi. 10.1111/j.1368-5031.2005.00531.x
- By:
- Publication type:
- Article
Erectile function recovery in patients after non-nerve sparing radical prostatectomy.
- Published in:
- Andrology, 2014, v. 2, n. 6, p. 951, doi. 10.1111/andr.282
- By:
- Publication type:
- Article
Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease.
- Published in:
- International Journal of Impotence Research, 2004, v. 16, n. 3, p. 288, doi. 10.1038/sj.ijir.3901170
- By:
- Publication type:
- Article
Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.
- Published in:
- International Journal of Impotence Research, 2004, v. 16, n. 2, p. 99, doi. 10.1038/sj.ijir.3901183
- By:
- Publication type:
- Article
Expanding the paradigm for plaque development in Peyronie's disease.
- Published in:
- International Journal of Impotence Research, 2003, v. 15, p. S93, doi. 10.1038/sj.ijir.3901082
- By:
- Publication type:
- Article
Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses.
- Published in:
- International Journal of Impotence Research, 2002, v. 14, n. 5, p. 397, doi. 10.1038/sj.ijir.3900874
- By:
- Publication type:
- Article
Perturbation of cell cycle regulators in Peyronie's disease.
- Published in:
- International Journal of Impotence Research, 2001, v. 13, n. 6, p. S21, doi. 10.1038/sj.ijir.3900771
- By:
- Publication type:
- Article
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents.
- Published in:
- International Journal of Impotence Research, 2000, v. 12, n. 4, p. S25, doi. 10.1038/sj.ijir.3900558
- By:
- Publication type:
- Article
(O-28) CHRONOLOGY OF ENDOGENOUS TESTOSTERONE RECOVERY AFTER DISCONTINUATION OF ANDROGEN DEPRIVATION THERAPY - RESULTS FROM A PROSPECTIVE ANALYSIS.
- Published in:
- Journal of Sexual Medicine, 2024, v. 21, p. 1, doi. 10.1093/jsxmed/qdae018.022
- By:
- Publication type:
- Article
Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection.
- Published in:
- Human Reproduction, 1997, v. 12, n. 3, p. 503, doi. 10.1093/humrep/12.3.503
- By:
- Publication type:
- Article